In the wake of this week’s allegations, Ryan Adams‘ upcoming album, Big Colors, is being “put on hold,” sources close to the situation told Variety. In The New York Times exposé published on Wednesday, seven women accuse Adams of wielding his music industry clout to emotionally abuse and sexually manipulate them. The report cites seven different women, including Adams’ ex-wife Mandy Moore, rising artist Phoebe Bridgers, and more, and describes a pattern in which offers of career assistance repeatedly turned into sexual advances and romantic relationships became emotionally abusive. The report also details a domineering and sexually inappropriate correspondence Adams allegedly had with an underage girl over a 9-month span.Big Colors was set for release on April 19th, but retailers began to report on Thursday evening that the album was pulled from release schedules by Universal Music Group, the parent company of Adams’ own label, Pax-Am, which has a distribution deal with Blue Note Records. Pax-Am has also deleted the Big Colors pre-order pages on its own website. Big Colors was originally set to be Adams’ first of three albums in 2019, though the fate of that plan now appears to be uncertain.Beyond the album, three different companies with whom Ryan Adams was attached for endorsement deals have officially severed ties with the artist. Included in this list is Benson Amps, who announced a Ryan Adams signature model amp at last year’s NAMM convention. Christopher Benson, the company’s principal, said in a statement. “We are saddened and surprised by the recent allegations against Mr. Ryan Adams as documented in the New York Times. … We have decided to suspend our relationship with Mr. Adams at this moment, and will no longer move forward with the development of the Ryan Adams signature model. We have no further comment at this time.”The presidents of JHS Pedals and Walrus Audio, which both had Ryan Adams signature products on the market when the story broke, both issued similar statements pulling their Adams products. As JHS Pedals president Josh Scott noted, “Because of my deep concern over this situation, I am ceasing all collaboration with Ryan and have discontinued the VCR Ryan Adams Signature Pedal. We have a remaining stock of VCR pedals and are making future plans to fully rebrand and sell this inventory with a portion of the sale going towards the fight against sexual abuse and misconduct.”In addition to the business partnership fallout, The New York Times reported Thursday that the F.B.I. is now looking into “whether the singer-songwriter Ryan Adams, 44, committed a crime by engaging in sexually explicit communications with an underage fan.” Adams, through his lawyer, Andrew B. Brettler, has denied that he “ever engaged in inappropriate online sexual communications with someone he knew was underage.”
Editor’s note: This story was updated Aug 7 to include information about the start of influenza vaccine shipments by Novartis.Aug 6, 2008 (CIDRAP News) – The six companies that make influenza vaccine for the US market have won federal approval for their version of this year’s vaccine, in which all three flu strains used in last year’s product have been replaced, the Food and Drug Administration (FDA) announced yesterday.The FDA announcement clears the way for marketing of the vaccines. At least three vaccine makers have begun shipping vaccine to distributors and providers, according to recent company announcements.The six manufacturers and their vaccines are CSL Limited, Afluria; GlaoxSmithKline Biologicals, Fluarix; ID Biomedical Corp. of Quebec (a unit of GlaxoSmithKline), FluLaval; MedImmune, FluMist; Novartis Vaccines and Diagnostics, Fluvirin; and Sanofi Pasteur, Fluzone.In the wake of a relatively poor match between the vaccine and circulating flu strains last season, experts at the World Health Organization and the FDA in February recommended changing all three strains of virus used in the vaccine. In most years only one or two of the three strains are changed.”One of the biggest challenges in the fight against influenza is producing new vaccines every year,” Jesse Goodman, MD, MPH, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release. “There is no other instance where new vaccines must be made every year.”Two of the three strains in the 2008-09 vaccine are included in vaccines now being used in the Southern Hemisphere, where the flu season is under way, the FDA noted.The decision to change all three strains in the vaccine had generated some concern about possible production delays or low yields of the viruses, which are grown in eggs. But Curtis Allen, a spokesman for the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC) in Atlanta, said today he hasn’t heard of any problems growing the strains.”Vaccine production is always fraught with risk and anywhere along the line things can go wrong, but so far they have not, and we’re looking forward to a season with adequate supplies of vaccine,” Allen told CIDRAP News.At a meeting in May, manufacturers estimated they would produce a record total of 143 million to 146 million doses of flu vaccine for the US market this year. Allen said the estimates of vaccine production have not changed since then. Last year 140 million doses were produced.Allen listed the manufacturers’ production estimates as follows: Sanofi Pasteur, 50 million doses; GlaxoSmithKline (including ID Biomedical), 35 million to 38 million; MedImmune, 12 million; Novartis, 40 million; and CSL, 6 million.Sanofi announced Aug 1 that it had begun shipping the first 1.3 million doses of Fluzone. “Vaccine shipments to healthcare providers and to the [CDC] for distribution through the Vaccines for Children Program will continue through the fall and are planned to be completed in October,” the company said in a news release.The statement indicated that replacing all three strains of virus has not caused any major production problems.”Introduction of three new strains for the influenza vaccine was unprecedented and could have resulted in a low yield or delay given our tight production timeline. Despite these challenges, we are pleased that once again Sanofi Pasteur has demonstrated its reliability in supplying Fluzone vaccine to the US market,” said Wayne Pisano, the company’s president and chief executive officer, in the news release.MedImmune announced yesterday that shipments of FluMist, a nasal-spray vaccine that uses a weakened form of live virus, had begun on Jul 31. In a news release, the company affirmed that it plans to produce about 12 million doses, a record number.FluMist will be available at some retail pharmacies and supermarkets and in nearly 200 school-based vaccination programs and university health centers, the company said. In addition, the federal government, as in past years, is buying some doses for use in military personnel, officials said.Novartis announced Aug 7 that it has begun shipping Fluvirin to US healthcare providers. The company said it expects to deliver 20 million doses by the end of September and aims to deliver the remaining 20 million by Oct 31. Officials said the company has added a second manufacturing facility, located in Rosia, Italy, to help supply flu vaccine earlier in the season. The firm’s other facility is in Liverpool, England.”Despite the new composition [of the vaccine], Novartis made sure we were able to deliver a timely and robust supply of influenza vaccine this year,” said Rajiv De Silva, president of Novartis Vaccines in the US, in a news release.This is the first year the CDC is formally recommending flu shots for school-age children, adding about 30 million people to the ranks of those targeted for vaccination. Allen said the total number of those targeted for vaccination—including people at risk for serious flu complications and their close contacts—is about 258 million, or roughly 84% of the population.See also: Aug 5 FDA news releasehttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116933.htmFDA page with chart of vaccine lot releaseshttp://www.fda.gov/cber/flu/flu2008.htmAug 4 MedImmune news releaseAug 1 Sanofi Pasteur news releasehttp://www.vaccineplace.com/docs/first_shipment_release.pdfMay 13 CIDRAP News story “Flu experts try to ensure record vaccine doses get used”Feb 22 CIDRAP News story “FDA endorses overhaul for 2008-09 flu vaccine”
According to police investigators,Mahinay and Lumangyao were having a drinking session when a heated argumentensued between them on Dec. 1. Mahinay was brought to the CorazonLocsin Montelibano Memorial Regional Hospital here for treatment. Police identified the suspect as38-year-old resident Jerson Lumangyao. Officers of Police Station 7 conducteda manhunt operation against Lumangyao, who fled after the incident./PN This prompted Lumangyao to stabMahinay, police said. Bacolod City – A man was stabbed in Barangay Vista Alegre. The 43-year-old resident DamasinoMahinay sustained a stab wound on the back, a police report showed. Mahinay punched Lumangyao, the reportadded.
The specialty grocery store Trader Joe’s is the first confirmed tenant for the new student residential and retail complex, USC Village, a project that officially broke ground on Sept. 15. It will start serving the university community beginning in fall 2017.Dan Bane, the current chairman and CEO of the company, is a 1969 graduate of USC.The 12,700-square-foot Trader Joe’s will be on the corner of Jefferson Boulevard and Hoover Street. The L.A.-based grocery chain has spread to more than 400 locations in 40 states since 1958.”We’re excited to be part of the USC Village and we look forward to being a positive addition to the neighborhood in the years to come,” Alison Mochizuki, director of public relations for Trader Joe’s, said.In a press release, Trader Joe’s said their location at The Village will combine current store aesthetics with community influences.“The store will feature a festive décor that mixes traditional Trader Joe’s elements such as cedar covered walls and Hawaiian motifs, combined with a local flair that includes art celebrating the neighborhood,” the company stated in a press release.Students have expressed interest in the grocery store, as it will greatly expand campus food options.”I think it’ll be really nice to have a healthy, affordable dining option on campus aside from Seeds,” Harshini Chengareddy, a freshman majoring in global health said.At the USC Village groundbreaking ceremony on Monday, President C.L. Max Nikias stressed that the campus expansion will serve as an enormous benefit to both the school and surrounding community.“In the past four years, we have been privileged to break ground on a number of new projects at USC. But this village is an especially historic moment for USC, for our neighborhood and for Los Angeles as a whole,” Nikias said.In addition to Trader Joe’s, USC Village will include a fitness center, drugstore, Trojan Town USC store, restaurants, parking and a community room. Bank of America and Starbucks coffee will return as well. The project also includes building residence halls for up to 2,700 honors students and a Gothic-style clock tower.The $650 million project is one of the biggest developments USC has undertaken, along with one of the largest in South Los Angeles’ history. This new development will be built on 15 acres of USC-owned land without public subsidies or taxpayer funds. USC is also providing over $40 million in community benefits and plans to redesign and improve Jefferson Boulevard in the funding of new streets, a new fire station, a law clinic, a small business adviser and ombudsmen.USC, the largest private employer in Los Angeles, hopes The Village project will create both temporary and permanent jobs in the surrounding community.
US-based Ghanaian juvenile boxer, Joseph Awinongya Jnr, has made a commitment to financially support Paulina Anokye to undergo surgery to remove a spinal tumour.Joseph saw the deteriorating condition of Paulina Anokye on YouTube on a local online magazine show dubbed “Common Sense Family” (CSF) hosted by Avram Ben Moshe. He was touched by the plight of Paulina and discussed with his dad Joseph Awinongya Snr how he can reach out to support Paulina.“I showed the video to my dad and he asked me to choose between getting a Play Station 5 which I so much desire to have and supporting Paulina with the funds” Awinongya Jnr said.“I chose to help Paulina and forget about the Play Station because her condition gradually is killing her because of money” he added.Paulina Anokye who is a native of Kwadaso a suburb of Kumasi in the Ashanti region of Ghana was diagnosed with spinal tumor at age fourteen when she started experiencing immobility in her left fingers.Due to lack of finance to correct the defect, she resorted to herbal treatment which further deteriorated her condition affecting her right arm and both legs rendering her paralysed. He has committed to supporting Paulina by paying for her medical assistance fees and an undisclosed amount for her up keep for four months after her surgery. Paulina be will admitted at the Okomfo Anokye Teaching hospital where she has been booked for surgery on 22nd of July 2020.The 13-year-old is currently rated number one and two in the 90lbs and 95lbs divisions in America has won almost all competition he has participated.He has shown a superb exhibition of boxing artistry, a rare display of boxing IQ, academic excellence and has become the toast of many in Ghana and Chicago where he lives with his family.Awinongya Jnr. also known as Jojo has won many awards since he ventured into the sport when he was five years.He is a three-time Silver Gloves National Champ, 1x USA National Champion, 2x Jr Olympic National Champion, 1x Western Elite Qualifier National Champion, 2x St Louis National Champion, 1x King of the Jungle National Champion, 2 x Wisconsin National Champion, and Power Gloves National Champion His sterling performance in and off the ring in his young career won him the Gold Star Award for Community Service by the black community in America (National Hook-UP of Black Women Inc) for being an outstanding role model in November 2019.Early this year he was admitted to The Better Chance Program, a prestigious college preparatory school in New York for excelling young talents.